Prion and TNFα: TAC(E)it agreement between the prion protein and cell signaling

Cell Cycle

Volumn 9, Issue 23, 2010, Pages 4616-4621

  Stella, Roberto ^a   Massimino, Maria Lina ^a   Sorgato, M Catia ^a   Bertoli, Alessandro ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

ADAM; Alzheimer disease; Prion; PrP; TACE; TNF

Indexed keywords

ADAM PROTEIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PRION PROTEIN; PROTEIN KINASE B; PROTEINASE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL CYCLE; CYTOKINE RELEASE; DEGENERATIVE DISEASE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; IMMUNE SYSTEM; KNOCKOUT MOUSE; MAJOR CLINICAL STUDY; MORPHOGENESIS; MOUSE; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRION DISEASE; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

MUS;

EID: 78650114658     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.23.14135     Document Type: Review

References (51)

1. Aguzzi A, Calella AM. Prions: protein aggregation and infectious diseases. Physiol Rev 2009; 89:1105-52.
2. Sigurdson CJ, Aguzzi A. Chronic wasting disease. Biochim Biophys Acta 2007; 1772:610-8.
3. Genovesi S, Leita L, Sequi P, Andrighetto I, Sorgato MC, Bertoli A. Direct detection of soil-bound prions. PLoS One 2007; 2:1069.
4. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363-83.
5. Büeler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992; 356:577-82.
6. Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, Hope J. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 1994; 8:121-7.
7. Mallucci GR, Ratté S, Asante EA, Linehan J, Gowland I, Jefferys JG. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J 2002; 21:202-10. (Pubitemid 34137282)
8. Büeler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, et al. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73:1339-47. (Pubitemid 23201147)
9. Criado JR, Sanchez-Alavez M, Conti B, Giacchino JL, Wills DN, Henriksen SJ, et al. Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol Dis 2005; 19:255-65. (Pubitemid 40544743)
10. Nazor KE, Seward T, Telling GC. Motor behavioral and neuropathological deficits in mice deficient for normal prion protein expression. Biochim Biophys Acta 2007; 1772:645-53. (Pubitemid 46880209)
11. Aguzzi A, Baumann F, Bremer J. The prion's elusive reason for being. Annu Rev Neurosci 2008; 31:439-77.
12. Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008; 88:673-728.
13. Stella R, Massimino ML, Sandri M, Sorgato MC, Bertoli A. Cellular prion protein promotes regeneration of adult muscle tissue. Mol Cell Biol 2010; 30:4864-76.
14. Chen SE, Gerken E, Zhang Y, Zhan M, Mohan RK, Li A, et al. Role of TNFalpha signaling in regeneration of cardiotoxin-injured muscle. Am J Physiol Cell Physiol 2005; 289:1179-87.
15. Chen SE, Jin B, Li YP. TNFalpha regulates myogenesis and muscle regeneration by activating p38 MAPK. Am J Physiol Cell Physiol 2007; 292:1660-71.
16. Zhan M, Jin B, Chen SE, Reecy JM, Li YP. TACE release of TNFalpha mediates mechanotransduction-induced activation of p38 MAPK and myogenesis. J Cell Sci 2007; 120:692-701. (Pubitemid 46437903)
17. Zetser A, Gredinger E, Bengal E. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J Biol Chem 1999; 274:5193-200.
18. Wu Z, Woodring PJ, Bhakta KS, Tamura K, Wen F, Feramisco JR, et al. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol Cell Biol 2000; 20:3951-64. (Pubitemid 30314494)
19. Simone C, Forcales SV, Hill DA, Imbalzano AN, Latella L, Puri PL. p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat Genet 2004; 36:738-43. (Pubitemid 38886636)
20. Albini S, Puri PL. SWI/SNF complexes, chromatin remodeling and skeletal myogenesis: it's time to exchange! Exp Cell Res 2010; 316:3073-80.
21. Cabane C, Englaro W, Yeow K, Ragno M, Dérijard B. Regulation of C2C12 myogenic terminal differentiation by MKK3/p38alpha pathway. Am J Physiol Cell Physiol 2003; 284:658-66.
22. Serra C, Palacios D, Mozzetta C, Forcales SV, Morantte I, Ripani M, et al. Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation. Mol Cell 2007; 28:200-13. (Pubitemid 47599998)
23. Palacios D, Mozzetta C, Consalvi S, Caretti G, Saccone V, Proserpio V, et al. TNF/p38α/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. Cell Stem Cell 2010; 7:455-69.
24. Steele AD, Emsley JG, Ozdinler PH, Lindquist S, Macklis JD. Prion protein (PrPc) positively regulates neural precursor proliferation during developmental and adult mammalian neurogenesis. Proc Natl Acad Sci USA 2006; 103:3416-21. (Pubitemid 43346483)
25. Prestori F, Rossi P, Bearzatto B, Lainé J, Necchi D, Diwakar S, et al. Altered neuron excitability and synaptic plasticity in the cerebellar granular layer of juvenile prion protein knock-out mice with impaired motor control. J Neurosci 2008; 28:7091-103.
26. Sorgato MC, Peggion C, Bertoli A. Is, indeed the prion protein a Harlequin servant of "many" masters? Prion 2009; 3:202-5.
27. Black RA. Tumor necrosis factoralpha converting enzyme. Int J Biochem Cell Biol 2002; 34:1-5. (Pubitemid 33152908)
28. Gooz M. ADAM-17: the enzyme that does it all. Crit Rev Biochem Mol Biol 2010; 45:146-69.
29. Edwards DR, Handsley MM, Pennington CJ. The ADAM metalloproteinases. Mol Aspects Med 2008;29:258-89.
30. Reiss K, Saftig P. The "a disintegrin and metalloprotease" (ADAM) family of sheddases: physiological and cellular functions. Semin Cell Dev Biol 2009;20:126-37.
31. Zhang Z, Oliver P, Lancaster JR Jr, Schwarzenberger PO, Joshi MS, Cork J, et al. Reactive oxygen species mediate tumor necrosis factoralpha-converting, enzyme-dependent ectodomain shedding induced by phorbol myristate acetate. FASEB J 2001; 15:303-5.
32. Taylor DR, Parkin ET, Cocklin SL, Ault JR, Ashcroft AE, Turner AJ, et al. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein. J Biol Chem 2009; 284:22590-600.
33. Vincent B, Paitel E, Saftig P, Frobert Y, Hartmann D, De Strooper B, et al. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem 2001; 276:37743-6.
34. Cissé MA, Sunyach C, Lefranc-Jullien S, Postina R, Vincent B, Checler F. The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity. J Biol Chem 2005; 280:40624-31. (Pubitemid 41780553)
35. Alfa Cissé M, Sunyach C, Slack BE, Fisher A, Vincent B, Checler F. M1 and M3 muscarinic receptors control physiological processing of cellular prion by modulating ADAM17 phosphorylation and activity. J Neurosci 2007; 27:4083-92. (Pubitemid 46597172)
36. Costa MD, Paludo KS, Klassen G, Lopes MH, Mercadante AF, Martins VR, et al. Characterization of a specific interaction between ADAM23 and cellular prion protein. Neurosci Lett 2009; 46:16-20.
37. Pradines E, Loubet D, Mouillet-Richard S, Manivet P, Launay JM, Kellermann O, et al. Cellular prion protein coupling to TACE-dependent TNFalpha shedding controls neurotransmitter catabolism in neuronal cells. J Neurochem 2009; 110:912-23.
38. Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, et al. The cellular prion protein binds copper in vivo. Nature 1997; 390:684-7. (Pubitemid 28016355)
39. Watt NT, Hooper NM. The prion protein and neuronal zinc homeostasis. Trends Biochem Sci 2003; 28:406-10. (Pubitemid 36976742)
40. Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 2007; 8:101-12. (Pubitemid 46432529)
41. Nimmrich V, Ebert U. Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid. Rev Neurosci 2009; 20:1-12.
42. Walter J, Kaether C, Steiner H, Haass C. The cell biology of Alzheimer's disease: uncovering the secrets of secretases. Curr Opin Neurobiol 2001; 11:585-90. (Pubitemid 32938290)
43. Haass C. Take five - BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. EMBO J 2004; 23:483-8. (Pubitemid 38282380)
44. Müller T, Meyer HE, Egensperger R, Marcus K. The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis and cytoskeletal dynamics-relevance for Alzheimer's disease. Prog Neurobiol 2008; 85:393-406.
45. Parkin ET, Watt NT, Hussain I, Eckman EA, Eckman CB, Manson JC, et al. Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein. Proc Natl Acad Sci USA 2007; 104:11062-7. (Pubitemid 47175226)
46. Kellett KA, Hooper NM. Prion protein and Alzheimer disease. Prion 2009; 3:190-4.
47. Hooper NM, Turner AJ. A new take on prions: preventing Alzheimer's disease. Trends Biochem Sci 2008; 33:151-5.
48. Allinson TM, Parkin ET, Turner AJ, Hooper NM. ADAMs family members as amyloid precursor protein alpha-secretases. J Neurosci Res 2003; 74:342-52. (Pubitemid 37362810)
49. Hooper NM. Roles of proteolysis and lipid rafts in the processing of the amyloid precursor protein and prion protein. Biochem Soc Trans 2005; 33:335-8. (Pubitemid 40604366)
50. Vardy ER, Catto AJ, Hooper NM. Proteolytic mechanisms in amyloid-beta metabolism: therapeutic implications for Alzheimer's disease. Trends Mol Med 2005; 11:464-72. (Pubitemid 41415726)
51. Fahrenholz F. Alpha-secretase as a therapeutic target. Curr Alzheimer Res 2007; 4:412-7.